Why the study?
The pathogenesis of pediatric orthostatic hypertension remains unclear, prompting a review of clinical studies on its pathogenesis, clinical characteristics, diagnostic criteria, and treatment to guide future research.
Pediatric orthostatic hypertension is an important cause of orthostatic intolerance in older children, currently managed primarily with non-pharmacological interventions.
Orthostatic hypertension merits attention in pediatric syncope; leaves open pathogenesis and hypertension progression risks.
The concept of orthostatic hypertension in children was first proposed in 2012. The pathogenesis is not clear by now. Orthostatic hypertension is one of the important causes of orthostatic intolerance in children and is related to the development of essential hypertension in the future. It is commonly seen in older children, with dizziness and syncope as their main clinical manifestations. Non-drug therapy is the commonly used treatment strategy, which is effective to improve the orthostatic intolerance symptoms. In this paper, we reviewed the clinical studies on the pathogenesis, clinical characteristics, diagnostic criteria, and treatment of orthostatic hypertension in children, aiming to provide new insights for the future studies on pediatric orthostatic hypertension.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: